Computer‐Assisted Analysis of Histamine H2− and H3‐Receptor Agonists
暂无分享,去创建一个
[1] C. Ganellin. Conformation of histamine derivatives. 3. A relationship between conformation and pharmacological activity. , 1973, Journal of medicinal chemistry.
[2] M. Parsons,et al. Two novel, potent and selective histamine H3 receptor agonists , 1992 .
[3] H. Timmerman,et al. New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists. , 1993, Molecular pharmacology.
[4] R. Leurs,et al. A new potent and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine. , 1994, Journal of medicinal chemistry.
[5] H. Timmerman,et al. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles. , 1992, Journal of medicinal chemistry.
[6] J. Schwartz,et al. Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.
[7] A. Bast,et al. Characterization of the binding of the first selective radiolabeled histamine H3‐receptor antagonist, [125I]‐iodophenpropit, to rat brain , 1994, British journal of pharmacology.
[8] A. Bast,et al. HA autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation. , 1987, European journal of pharmacology.
[9] J. Schwartz,et al. Imetit and N-methyl derivatives. The transition from potent agonist to antagonist at histamine H3 receptors.1 , 1992 .